Vridapa-MS Tablet ER

Overview Vridapa-MS Tablet ER

Glycemia-Control ER tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, enhances blood sugar regulation in adults with type 2 diabetes. It improves insulin effectiveness, thus reducing blood sugar. Glycemia-Control ER can be ingested with or without food, but consistent daily timing is recommended. Dosage is determined by your physician; discontinuation requires their consultation, as cessation may elevate blood sugar, raising the risk of severe complications such as nephropathy and vision impairment. This medication complements a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Common side effects include urinary tract infections, nasal congestion, pharyngitis, and upper respiratory infections. Adequate hydration mitigates dehydration. Genital fungal infections are a potential side effect; meticulous hygiene helps prevent this. Prior to initiating Glycemia-Control ER, discuss any kidney or liver issues, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating individuals should consult their physician. Limit alcohol consumption while using this medication, as it may intensify side effects. Regular blood glucose monitoring is essential during treatment.

Uses of Vridapa-MS Tablet ER

Managing type 2 diabetes

Major Benefits of Vridapa-MS Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vridapa-MS Tablet ER whole; do not attempt to crush, chew, or fracture it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.

Common Side effects of Vridapa-MS Tablet ER:

• Diarrhea
• Nausea
• Vomiting
• Flatulence
• Polyuria
• Dyslipidemia
• Genital fungal infection
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Headache
• Hypoglycemia (low blood glucose level)
• Conjunctivitis
• Cough

How to use Vridapa-MS Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Vridapa-MS Tablet ER. Ingest the tablet whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, however, consistency in timing is recommended.

How Vridapa-MS Tablet ER works:

Vridapa-MS Extended-Release tablets contain a triple-action formulation for diabetes management. Dapagliflozin promotes glucose elimination via the kidneys, consequently lowering blood glucose. Metformin works on multiple fronts: reducing intestinal glucose absorption, diminishing hepatic glucose production, and enhancing insulin sensitivity to better regulate blood sugar. Sitagliptin boosts incretin levels, stimulating pancreatic insulin release and suppressing excessive hepatic glucose output.

What if you forget to take Vridapa-MS Tablet ER :

NA